SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are ...
The QuickVue® At-Home COVID-19 Test employs the same Quidel lateral flow technology used for decades by healthcare professionals and features the same SARS CoV-2 rapid antigen test strip and reagent ...
After a bit of a rough patch, things are looking up for Quidel and its diagnostic offerings. The San Diego-based company snagged a CE mark for its Savanna molecular testing platform and the first ...
San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...
A new at-home COVID test has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). Below is what you need to know about the at-home test. How can I get a Quidel ...
Shares of Quidel Corp. (QDEL) jumped Monday on the heels of the U.S. Food and Drug Administration’s emergency use authorization for the company’s rapid-result Covid-19 test amid a push to ramp up ...
Between 2017 and 2020, Abbott’s revenues grew by about 26%, from around $27.4 billion to $34.6 billion, primarily led by a strong growth in diagnostics business, which saw its revenue nearly double to ...
Rival Abbott is looking to become the dominant player in the coronavirus test arena. Quidel fell the most because its COVID-19 test, the Sofia SARS Antigen FIA, is in the same class as Abbott's ...